Safety data Safety data Main navigation COVID-19 vaccines Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine AusVaxSafety is an active vaccine safety surveillance system that monitors the safety of vaccines in Australia. Using de-identified data reported directly from people receiving the vaccines (or their parent or carer), AusVaxSafety monitors adverse events following immunisation and facilitates early detection of potential vaccine safety issues. More information on AusVaxSafety active vaccine safety surveillance here. COVID-19 vaccines AusVaxSafety is conducting active surveillance of COVID-19 vaccine safety. Click here to access the latest data. Influenza vaccines AusVaxSafety is undertaking active surveillance of 2023 influenza vaccine safety. Click here to access the latest data. National Immunisation Program Schedule vaccines AusVaxSafety is undertaking active surveillance of NIP vaccine safety. Click here to access the latest data. Mpox (monkeypox) vaccine AusVaxSafety is conducting active surveillance of mpox vaccine safety. Click here to access the latest data. Safety data Main navigation COVID-19 vaccines Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine News & events All news & events 14 September 2023 | News Vaxtracker wins Hunter New England Health Excellence Award 17 May 2023 | News Subcutaneous and intradermal administration of mpox vaccine well tolerated, AusVaxSafety study finds 10 May 2023 | News New bivalent BA.4/BA.5 COVID-19 booster vaccines well tolerated by Australians, new AusVaxSafety data show 20 April 2023 | News Influenza is back in Australia in 2023: Why a flu shot is so important, who is eligible and what to expect in the days following your vaccination